文献速递肿瘤 PET/CT

正电子发射断层显像-磁共振成像(PET-MRI)用于宫颈癌放疗后疗效评估:一项先导研究

Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study.
PubMed 文献 · EJNMMI Res · 2018-01-02

这项先导研究前瞻性评估了10例FIGO≥IB2宫颈癌患者放疗后中位11周(范围8-15周)的PET-MRI疗效评估表现,结果显示PET与MRI联合使80-90%患者诊断信心提高,70%出现意见改变、50%出现处理策略改变,放射科医师联合PET-MRI后诊断准确率显著提高(AUC 0.54 vs 0.83)。

要点

  • 10例宫颈癌患者放疗后中位11周行PET-MRI评估,3例提示局部肿瘤残留。
  • PET与MRI联合使80-90%患者诊断信心提高,70%出现意见改变、50%出现处理策略改变。
  • 放射科医师联合PET-MRI后诊断准确率显著提高(AUC 0.54 vs 0.83)。

核心结论

  • PET-MRI在宫颈癌放疗后疗效评估中显示出前景,尤其可提高诊断信心,并可能提高诊断效能。

研究设计与样本

  • 前瞻性先导研究,纳入10例宫颈癌(FIGO≥IB2)患者,放疗后中位11周(范围8-15周)行PET-MRI评估疗效。
  • 由读片者对结局数据设盲,分别评估PET、MRI及联合PET-MRI图像上局部残留肿瘤和转移的存在。
  • 以病理和/或按临床指南的随访作为参考标准,诊断效能用受试者工作特征(ROC)曲线下面积评估。
  • 局部残留病变、转移、诊断信心和意见改变采用5点Likert量表评分。

主要发现

  • 10例患者中3例在放疗后存在提示肿瘤残留的局部异常。
  • 同时获得PET和MRI使80-90%患者的诊断信心提高。
  • 70%患者出现意见改变,50%出现处理策略改变,尤其在存在残留肿瘤的组中。
  • 放射科医师联合PET-MRI后诊断准确率显著提高(AUC 0.54 vs 0.83)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is controversial. Positron emission tomography (PET) combined with computer tomography (PET-CT) shows great promise for detecting metastases. On the other hand, magnetic resonance imaging (MRI) is superior in depicting anatomical details. The combination of PET-MRI could result in more accurate evaluation of cervical cancer treatment outcome. The aim of this pilot study is to share our initial experience with PET-MRI in the evaluation of treatment response in cervical cancer after radiation treatment. METHODS: Ten patients with cervical carcinoma (FIGO ≥IB2) were prospectively evaluated. Eleven weeks (median; range 8-15 weeks) after radiation therapy, treatment response was evaluated by PET-MRI. The PET, MRI, and combined PET-MRI images were evaluated for the presence of local residual tumor and metastasis. Diagnostic performance was assessed by area under the receiver operator characteristic (ROC) curve for evaluation of local residual tumor. The readers were blinded for outcome data. Local residual disease, metastasis, diagnostic confidence, and change of opinion were scored on a 5-point Likert scale. The reference standard consisted of pathology and/or follow-up according to the clinical guidelines. RESULTS: Three out of ten patients had local residual abnormalities suggestive for tumor residue after radiation treatment. The availability of both PET and MRI resulted in an increase in diagnostic confidence in 80-90% of all patients. Change of opinion was observed in 70% and change of policy in 50%, especially in the group with residual tumor. The diagnostic accuracy increased significantly for the radiologist if PET-MRI was combined (AUC .54 versus .83). CONCLUSIONS: PET-MRI shows promise for evaluation of treatment response after radiation for cervical cancer, especially increasing diagnostic confidence, while potentially increasing diagnostic performance.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Mongula JE, Bakers FCH, Vöö S, et al. Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study. EJNMMI Res. 2018. PMID: 29292485. doi:10.1186/s13550-017-0352-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。